Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Neil Mehta maintains a 'Buy' rating on Calumet Specialty Prods (NASDAQ:CLMT) but lowers the price target from $19 to $17.

October 31, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Goldman Sachs maintains a 'Buy' rating on Calumet Specialty Prods but lowers the price target from $19 to $17.
While Goldman Sachs maintains a 'Buy' rating on Calumet Specialty Prods, the lowering of the price target from $19 to $17 could potentially create some uncertainty among investors. However, the 'Buy' rating suggests that the firm still sees potential in the stock, which could balance out any negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100